Spironolactone Tablet, Film Coated
Product Images NDC 63629-1092

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 63629-1092). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Spironolactone 01)

FDA Label Image

Figure 1 (Spironolactone 02)

This is a medical study comparing the effectiveness of Spironolactone and Placebo. The result suggests that Spironolactone is statistically more effective than Placebo. The study was conducted for 48 months.*

FDA Label Image

Figure 2 (Spironolactone 03)

This appears to be a table presenting numerical data related to different variables in a medical study involving subgroups, diabetes, creatinine, potassium, and beta blockers. The table also includes a visual representation of the effectiveness of spironolactone compared to placebo over time.*

FDA Label Image

Lbl636291092

This is a medication label for Spironolactone Tablets, USP containing 100 mg of Spironolactone. The label advises to keep the medication out of reach of children and store it in a tight, light-resistant container at 20° to 25°C (68° to 77°F). It is also mentioned that the drug should be dispensed with a child-resistant closure. The NDC number for this drug is 63629-1092-1.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.